Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats

By Ueki Masaru   Koda Masahiko   Yamamoto Satoru   Matsunaga Yoshiko   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 41, Iss. 10, 2006-10 ,pp. : 996-1004

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Angiotensin II Receptor Type 1 Is Reduced in Advanced Rat Liver Fibrosis

By Töx Ulrich   Scheller Ingo   Kociok Norbert   Kern Michael   Klanac Dejan   Daudi Sharif   Laue Oliver   Schirmacher Peter   Goeser Tobias   Schulte Sigrid   Steffen Hans  

Digestive Diseases and Sciences, Vol. 52, Iss. 8, 2007-08 ,pp. : 1995-2005

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin II and Cardiac Fibrosis

By Brecher P.  

Trends in Cardiovascular Medicine, Vol. 6, Iss. 6, 1996-08 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

Effect of Losartan, an Angiotensin II Antagonist, on Hepatic Fibrosis Induced by CCl₄ in Rats

By Wei Yao Hong   Jun Li   Qiang Chen Ji  

Digestive Diseases and Sciences, Vol. 49, Iss. 10, 2004-10 ,pp. : 1589-1594

Springer Publishing Company

Access to resources Recommend Favorite

The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-β1/Smad2 expression

By He Jian-Gui   Chen Sheng-Long   Huang Yi-Yi   Chen Yi-Li   Dong Yu-Gang   Ma Hong  

Heart and Vessels, Vol. 25, Iss. 5, 2010-09 ,pp. : 438-443

Springer Publishing Company

Access to resources Recommend Favorite